Literature DB >> 30066794

Association between blood pressure and acute phase stroke case fatality rate: a prospective cohort study.

Natalia Eduarda Furlan1,2, Silméia Garcia Zanati Bazan1, Gabriel Pereira Braga1, Meire Cristina Novelli E Castro1, Roberto Jorge da Silva Franco1, Ana Lúcia Gut1, Rodrigo Bazan1, Luis Cuadrado Martin1.   

Abstract

OBJECTIVE: ed to investigate the association between blood pressure and acute phase stroke lethality in a Brazilian intensive care unit.
METHODS: This was an observational, prospective cohort study of hemorrhagic and ischemic stroke intensive care patients. The primary outcome was all-cause mortality during the first seven days.
RESULTS: There were 146 patients, aged 66 ± 13.4 years, 56% men, 89% Caucasian, 69% had ischemic stroke, and 80% were hypertensive. The median of the National Institutes of Health Stroke Scale score was 16. There were 101 ischemic stroke patients and 45 hemorrhagic stroke patients. In the ischemic stroke patients, logistic regression analysis identified low systolic blood pressure as an independent ominous prognostic factor and the optimal cut off was a mean of systolic blood pressure ≤ 131 mmHg during the first 48 hours from admission for prediction of death. No association was found for hemorrhagic stroke.
CONCLUSIONS: There was a negative association between systolic blood pressure and case fatality ratio of acute phase stroke in ischemic stroke intensive care patients.

Entities:  

Mesh:

Year:  2018        PMID: 30066794     DOI: 10.1590/0004-282X20180059

Source DB:  PubMed          Journal:  Arq Neuropsiquiatr        ISSN: 0004-282X            Impact factor:   1.420


  2 in total

1.  New Insights and Old Questions in Acute Stroke Blood Pressure Control.

Authors:  Gabriel Pinheiro Modolo; Luis Cuadrado Martin; Silméia Garcia Zanati Bazan; Rodrigo Bazan
Journal:  Neurocrit Care       Date:  2019-06       Impact factor: 3.210

2.  Blood Pressure Goals in Acute Stroke.

Authors:  Qian-Hui Guo; Chu-Hao Liu; Ji-Guang Wang
Journal:  Am J Hypertens       Date:  2022-06-16       Impact factor: 3.080

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.